Rabiesvaccine
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Antibiotics & Anti-Infectives treatment.
🧴 Clinical Application
Administered by a qualified healthcare provider via intramuscular injection into the deltoid muscle (never gluteal, as fat reduces efficacy) or certified intradermal regimen (Thai Red Cross protocol) on Days 0, 3, 7, and 14/28 as recommended by WHO/national guidelines. Category III exposures also require prompt local infiltration of Rabies Immunoglobulin (RIG).
⚠️ Side Effects
Common: Pain, erythema, swelling at injection site, low-grade fever, headache, nausea, malaise. Rare/Severe: Anaphylaxis, angioedema, Guillain-Barré syndrome, and encephalomyelitis.
🛡️ Safety Warnings
Post-exposure prophylaxis for rabies has NO absolute contraindications; because rabies is universally fatal, pregnancy, infancy, or illness are not reasons to withhold vaccination. Immediate thorough wound washing with soap and water for 15 minutes is vital prior to vaccination.
Jan Aushadhi Products containing Rabiesvaccine
Found 1 generic formulation(s) containing this active ingredient.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Rabiesvaccine.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Rabies Vaccine (Human) 2.5 IU Injection | 1 ml vial with diluent in Mono pack | ₹295.00 | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Rabiesvaccine generics.